Mm. Makarious et al., STUDIES OF GLOMERULAR PROTEIN-CONTENT IN THE DIABETIC HYPERTENSIVE RAT - THE EFFECT OF ANTIHYPERTENSIVE THERAPY, Nephrology, 2(1), 1996, pp. 39-44
The effects of enalapril and verapamil on glomerular protein content,
fractional mesangial area and glomerular basement membrane (GEM) thick
ness were examined in spontaneously hypertensive rats with streptozoto
cin-induced diabetes. Two groups of 16 animals received enalapril male
ate or verapamil to achieve normal blood pressure while a third untrea
ted group remained hypertensive throughout the 3 month experimental pe
riod. Blood glucose levels were maintained at 6-10 mmol/L in each grou
p. Creatinine clearance and 24 h urine protein were measured at second
weekly intervals. Glomerular protein and other structural parameters
were measured at the end of the experiment. Plasma angiotensin II (AII
) and glomerular AII receptors were also quantitated at the end of the
experiment. At 3 months, proteinuria was lowest in the enalapril-trea
ted animals while creatinine clearance was lower in the treated groups
than controls. Glomerular protein content (mu g/glomerulus) was lower
in the enalapril-treated group than verapamil-treated (P < 0.01) or u
ntreated rats (P < 0.05). Kidney weight, GEM thickness and fractional
mesangial area were also lowest in this group (P < 0.001 compared to o
ther groups). Glomerular AII receptor number was comparable among grou
ps when expressed as sites/glomerulus. The data suggest that enalapril
reduces glomerular protein content independently of blood pressure co
ntrol and that this effect corresponds with changes in mesangial area
and GEM thickness.